Search research articles
Contact Us
Filters
Showing results (81-90 of 125) with videos related to
Page
of 13
Sort By:
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C Deniger, Anna Pasetto, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer
Nachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Investigative Dermatology
|
November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology
Zoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
The Journal of Clinical Investigation
|
February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation
|
September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions
Paul F Robbins, Yong F Li, Mona El-Gamil, et al.
Cancer Immunology Research
|
February 3, 2019
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred Lo, Maria Parkhurst, Paul F Robbins, et al.
Nature Medicine
|
June 6, 2018
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis, Harshini Chinnasamy, Mary Black, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 125) with videos related to
Sort By:
Page
of 13
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C Deniger, Anna Pasetto, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer
Nachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Investigative Dermatology
|
November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology
Zoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
The Journal of Clinical Investigation
|
February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation
|
September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions
Paul F Robbins, Yong F Li, Mona El-Gamil, et al.
Cancer Immunology Research
|
February 3, 2019
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred Lo, Maria Parkhurst, Paul F Robbins, et al.
Nature Medicine
|
June 6, 2018
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis, Harshini Chinnasamy, Mary Black, et al.
Page
of 13